Use of comorbidity indices in patients with any cancer, breast cancer, and human epidermal growth factor receptor-2-positive breast cancer: A systematic review.
<h4>Objective</h4>To identify comorbidity indices that have been validated in cancer populations, with a focus on breast cancer and human epidermal growth factor receptor-2-positive (HER2+) breast cancer.<h4>Study design and setting</h4>A systematic review of the literature o...
Main Authors: | Maribel Salas, Mackenzie Henderson, Meera Sundararajan, Nora Tu, Zahidul Islam, Mina Ebeid, Laura Horne |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0252925 |
Similar Items
-
Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review
by: Michelle D. Hackshaw, et al.
Published: (2021-08-01) -
Validated Instruments of Quality of Life (QOL) in Patients With Acute Myeloid Leukemia (AML) and Other Cancers
by: Maribel Salas, et al.
Published: (2020-07-01) -
Serum Epidermal Growth Factor in Cancer Breast
by: El-Attar HA, et al.
Published: (2007-06-01) -
Epidermal growth factor receptors and human breast cancer
by: Sainsbury, J. R. C.
Published: (1986) -
Impact of Comorbidities on Quality Of Life in Breast Cancer Patients
by: Monica Irukulla, et al.
Published: (2016-12-01)